Brief: Regenxbio - Completes Dosing In Rgx-202 Confirmatory Study
BRIEF-Regenxbio - Completes Dosing In Rgx-202 Confirmatory Study June 24 (Reuters) - Regenxbio Inc RGNX.O:
REGENXBIO - COMPLETES DOSING IN RGX-202 CONFIRMATORY STUDY
REGENXBIO - ON TRACK TO INITIATE BLA FOR RGX-202 IN Q3 2026
Source text: ID:nPnbKjDPRa
Further company coverage: RGNX.O
((Reuters.Briefs@thomsonreuters.com;))